Phase II, multicenter, randomized, double-blind study, with subcutaneous immunotherapy in depot presentation, in parallel groups and placebo-controlled, in patients with rhinoconjunctivitis ± asthma sensitized to Olea europaea

Trial Profile

Phase II, multicenter, randomized, double-blind study, with subcutaneous immunotherapy in depot presentation, in parallel groups and placebo-controlled, in patients with rhinoconjunctivitis ± asthma sensitized to Olea europaea

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Allergy immunotherapy (Primary)
  • Indications Allergic rhinoconjunctivitis
  • Focus Pharmacodynamics
  • Sponsors Bial
  • Most Recent Events

    • 22 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top